Clinical Trial Update: A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase study to determine the preferred dose of lisinopril to prevent urinary toxicity after radiotherapy in men with prostate cancer, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lisinopril (Lisinopril)

Snippet

Sponsor: University of Rochester | Conditions: Prostate Cancer, Radiation Toxicity | EARLY_Phase 1 | Status: RECRUITING